Isomorphic Labs secures $600m to supercharge AI drug discovery
FierceBiotech - 31-Mar-2025Backed by Nobel science, the Alphabet spinout speeds up AI drug development
FierceBiotech
Web resource providing the latest biotech news, articles, and resources related to biotech company news
Biopharma is a fast-growing world where big ideas come along daily. Our readers rely on Fierce Biotech for the latest news, analysis and data on drugs and the companies that make them. Fierce Biotech covers the biopharma waterfront, from drug development through the entire lifecycle—tracking regulatory approvals, payer negotiations, manufacturing, marketing, patent fights, government investigations and regulation, M&A deals and beyond. Our aim is to analyze the day's news, showing readers not only what they need to know, but why they need to know it. Beyond the daily, the Fierce Biotech team produces special reports that take stock of the industry's products and finances, and shed new light on industry trends.
Visit website: https://www.fiercebiotech.com/
Details last updated 08-Feb-2019
People at FierceBiotech
Helen Floersh
Writer at Fierce Biotech, covering developments in basic science research and early-stage drug development.
Articles sourced from FierceBiotech
Bit.bio cuts 25% of staff as it shifts from therapy development to lab research
FierceBiotech - 19-Mar-2025Company aims to grow its product line and biotech partnerships
Vertex ends gene editing deal with Verve amid R&D shift
FierceBiotech - 27-Feb-2025Verve regains full rights to its liver disease program as it moves forward independently
Gene therapy restores hearing in children with rare deafness
FierceBiotech - 24-Feb-2025Regeneron’s DB-OTO offers new hope for genetic hearing loss
Cell therapy breakthrough offers new hope for type 1 diabetes
FierceBiotech - 08-Jan-2025Early trial results show promise for insulin production without immune suppression
ALS drug trials face setbacks but offer glimmers of hope
FierceBiotech - 07-Jan-2025Fosigotifator and DNL343 miss key goals, sparking calls for deeper analysis and longer studies
Khondrion's sonlicromanol faces setback in phase 2 trial, but holds onto hope
FierceBiotech - 22-Nov-2024Long-term follow-up data and post-hoc analyses fuel optimism for treating mitochondrial diseases
AI-developed drug improves lung function in idiopathic pulmonary fibrosis
FierceBiotech - 12-Nov-2024Drug improved chronic cough symptoms, contributing to a better quality of life\
Horizon Surgical raises $30M to enhance robotic cataract surgery
FierceBiotech - 21-Oct-2024Their Polaris system aims to improve cataract removal precision and consistency
Gilead strikes $35m AI drug discovery deal with Genesis
FierceBiotech - 10-Sep-2024The biotech’s advanced AI platform aims to unlock new treatments for challenging drug targets
Bioage prepares for IPO, targets obesity with new drug trials
FierceBiotech - 04-Sep-2024Biotech firm Bioage plans public debut as it advances promising obesity treatments
Race to treat rare disease heats up as Rafael and Cyclo join forces
FierceBiotech - 22-Aug-2024Pooling strengths to rival a competing therapy for Niemann-Pick type c1
Johnson & Johnson's Spine robot gets FDA clearance for advanced spine surgeries
FierceBiotech - 02-Aug-2024It will be available next year and is part of a series of advanced medical tools
Genentech discontinues cell therapy collaboration with Adaptimmune
FierceBiotech - 12-Apr-2024The company remains focused on its independent cancer drug development
Nanoscope's gene therapy offers hope for patients blinded by inherited retinal disease
FierceBiotech - 26-Mar-2024Phase 2 trial results show significant vision improvement, plans for FDA approval
MMI's surgical robot gears up for global rollout with $110M boost
FierceBiotech - 21-Feb-2024Symani's wristed instruments bring steady hands and big ambitions to microsurgery
Regenxbio-AbbVie gene therapy reduces eye injections for AMD patients
FierceBiotech - 17-Jan-2024Patients’ vision and retinal health remained stable after six months
Johnson & Johnson is developing a new robotic surgical system called Ottava
FierceBiotech - 10-Nov-2023Company is planning to begin clinical trials in the US in late 2024
Athersys faces setback as stroke therapy fails trial
FierceBiotech - 10-Oct-2023Enrollment paused, but $1.5 million secured from new partnership
World's first MRI-compatible surgical robot cleared by FDA for breast biopsies
FierceBiotech - 13-Sep-2023Safer, more accurate breast biopsies made possible with IGAR robot
Display all articles
